Bioavailability (F)
Bioavailability is the fraction of a dose that reaches the systemic circulation. With only oral data, F cannot be separated from clearance and volume; only CL/F and V/F can be estimated.
Frequently asked questions
Why does oral-only data give CL/F and not CL?
The concentration depends on dose × F, so a change in F is indistinguishable from the same change in CL and V; only the ratios CL/F and V/F are determined.
How is absolute bioavailability measured?
By comparing the AUC after an oral dose with the AUC after an intravenous dose in the same subjects, with a correction for the dose.
Does lower peak concentration mean lower bioavailability?
Slower absorption can lower the peak without changing the fraction reaching systemic circulation. Compare AUC under appropriate conditions.
Definition
Bioavailability (F) is the fraction of an administered dose that reaches the systemic circulation unchanged. For an intravenous dose F = 1. It is estimated by comparing the AUC after an oral dose with the AUC after an intravenous dose, corrected for the dose.
Apparent parameters
If only oral data are available, F cannot be separated from the clearance and the volume. What can be estimated are the apparent clearance CL/F and the apparent volume V/F. This is a case of structural identifiability: F, CL and V are not identifiable separately, whatever the number of samples.
On this site
The warfarin PK/PD analysis uses an oral one-compartment model and states that bioavailability cannot be separated from clearance or volume with these oral data, so apparent CL/F and V/F are reported.